Literature DB >> 19497402

Hybrid imaging technology: from dreams and vision to clinical devices.

James A Patton1, David W Townsend, Brian F Hutton.   

Abstract

Early in the history of nuclear medicine imaging it was realized that the nature of physiological mechanisms associated with the use of radiotracers prevented the identification of anatomic structures with a high degree of accuracy. This limitation often created difficulties in accurate interpretations of acquired images and caused investigators to seek methods of obtaining accurate anatomic correlations. Initial work centered on the use of software tools to combine anatomic and physiological data. Limitations in the use of these techniques, coupled with the development and refinements of anatomic imaging technologies (computed tomography [CT] and magnetic resonance imaging [MRI]), resulted in the development of hybrid imaging systems that combined CT with single-photon emission computed tomography (SPECT) and positron emission tomography (PET). With these hybrid systems, the images can be viewed separately or combined in a fused presentation for direct image correlation of anatomy and physiology. Presently, SPECT systems are available either with nondiagnostic CT capability for attenuation correction and image correlation, or with fully diagnostic CT capability, providing complementary diagnostic information. Equivalently, PET systems with diagnostic CT capability that provide high-resolution physiological and anatomic images are also now commercially available. These systems continue to evolve with the development of new detector materials and data acquisition and image processing technology. The widespread use of SPECT in cardiac imaging has resulted in the development of several new approaches to data acquisition and these new systems currently have either CT capability or the addition of this technology is planned in the future. The development and commercial availability of hybrid imaging systems has provided physicians with important new tools that significantly improve the diagnostic, staging, and treatment planning processes that are now available for their use.

Mesh:

Year:  2009        PMID: 19497402     DOI: 10.1053/j.semnuclmed.2009.03.005

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  17 in total

Review 1.  The origins of SPECT and SPECT/CT.

Authors:  Brian F Hutton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

Review 2.  Nuclear imaging of molecular processes in cancer.

Authors:  Rafael Torres Martin de Rosales; Erik Arstad; Philip J Blower
Journal:  Target Oncol       Date:  2009-09-25       Impact factor: 4.493

3.  Attenuation correction for myocardial perfusion SPECT imaging: still a controversial issue.

Authors:  Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-27       Impact factor: 9.236

4.  Prognostic value of extracardiac incidental findings on attenuation correction cardiac computed tomography.

Authors:  Waqas T Qureshi; Zaid Alirhayim; Fatima Khalid; Mouaz H Al-Mallah
Journal:  J Nucl Cardiol       Date:  2015-07-23       Impact factor: 5.952

5.  In vivo pentamodal tomographic imaging for small animals.

Authors:  Muhan Liu; Hongbo Guo; Hongbo Liu; Zeyu Zhang; Chongwei Chi; Hui Hui; Di Dong; Zhenhua Hu; Jie Tian
Journal:  Biomed Opt Express       Date:  2017-02-06       Impact factor: 3.732

6.  Impact of attenuation correction and gated acquisition in SPECT myocardial perfusion imaging: results of the multicentre SPAG (SPECT Attenuation Correction vs Gated) study.

Authors:  Dario Genovesi; Assuero Giorgetti; Alessia Gimelli; Annette Kusch; Irene D'Aragona Tagliavia; Mirta Casagranda; Giorgio Cannizzaro; Raffaele Giubbini; Francesco Bertagna; Giorgio Fagioli; Massimiliano Rossi; Annadina Romeo; Pietro Bertolaccini; Rita Bonini; Paolo Marzullo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-09       Impact factor: 9.236

7.  [SPECT/CT for staging and treatment monitoring in oncology. Applications in differentiated thyroid cancer and liver tumors].

Authors:  K Weber; F Berger; M Mustafa; M F Reiser; P Bartenstein; A Haug
Journal:  Radiologe       Date:  2012-07       Impact factor: 0.635

8.  Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.

Authors:  Brian A Hrycushko; Steve Ware; Shihong Li; Ande Bao
Journal:  Phys Med Biol       Date:  2011-08-12       Impact factor: 3.609

Review 9.  Positron emission tomography-magnetic resonance imaging: technical review.

Authors:  Raymond F Muzic; Frank P DiFilippo
Journal:  Semin Roentgenol       Date:  2014-10-18       Impact factor: 0.800

10.  Multimodal fluorescence-mediated tomography and SPECT/CT for small-animal imaging.

Authors:  Metasebya Solomon; Ralph E Nothdruft; Walter Akers; W Barry Edwards; Kexian Liang; Baogang Xu; Gail P Suddlow; Hamid Deghani; Yuan-Chuan Tai; Adam T Eggebrecht; Samuel Achilefu; Joseph P Culver
Journal:  J Nucl Med       Date:  2013-02-27       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.